emailEmail this page

printPrint this page

phoneFOR MORE INFORMATION ON OUR PRODUCTS, CONTACT A SALES REPRESENTATIVE at 800.388.8884, press 2.

Recommended Wolters Kluwer Health Products

FACTS & COMPARISONS®

Dose-Chek™ v2.0

Ensures Dosing Accuracy

ENABLES  DRUG DOSE SCREENING
Dose-Chek™ v2.0 supports dose and duration of therapy screening for both prescription and nonprescription drug products. The information provided in Dose-Chek™ v2.0 is comprehensive and age-specific. Cost of therapy can be determined when used in combination with pricing information from Master Drug Data Base v2.5 (MDDB®).

FEATURES

  • Minimum and maximum single and daily dose ranges for infant and pediatric patients
  • Minimum, maximum, and usual single and daily dose ranges for adult and geriatric patients
  • Minimum and maximum duration of therapy ranges for infant and pediatric patients
  • Minimum, maximum and usual duration of therapy dose ranges for adult and geriatric patients

BENEFITS

FOR PAYERS

  • Supports cost of therapy determinations
  • Screens for potentially inappropriate dosing or therapy duration
  • Supports prospective, concurrent and retrospective Drug Utilization Review (DUR) screening and analysis
  • Improves clinical outcomes by ensuring patients receive the proper medication dosage for the appropriate duration
  • Reduces risk of ineffective, toxic or unnecessary dosages
  • Reduces cost of unnecessary treatment due to inaccurate dosing or excessive duration
  • Click here to download the PDF

FOR PHARMACISTS

  • Supports cost of therapy determinations
  • Screens for potentially inappropriate dosing or therapy duration
  • Supports prospective, concurrent and retrospective Drug Utilization Review (DUR) screening and analysis
  • Improves clinical outcomes by ensuring patients receive the proper medication dosage for the appropriate duration
  • Reduces risk of ineffective, toxic or unnecessary dosages
  • Reduces cost of unnecessary treatment due to inaccurate dosing or excessive duration
  • Click here to download the PDF
Medi-Span®, a part of Wolters Kluwer Health, is the leading provider of prescription drug information and drug interactions databases for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer authoritative adverse drug reactions information and drug contraindications data in a variety of formats, including clinical decision support and disease suite modules, application programming interfaces and stand-alone software applications. Price Rx®, a Medi-Span product, offers drug pricing information for drug pricing analysis, formularly management and drug utilization review. In conjunction with superior implementation and experienced customer support, the Medi-Span product line is the perfect choice for those needing accurate, trusted drug data that easily integrates into existing software applications.